Vaxcell Bio (Korea) Today
| 323990 Stock | KRW 8,890 30.00 0.34% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Vaxcell Bio is trading at 8890.00 as of the 26th of March 2025, a 0.34 percent increase since the beginning of the trading day. The stock's open price was 8860.0. Vaxcell Bio has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. Vaxcell Bio is traded on Korean Securities Dealers Automated Quotations in South Korea. More on Vaxcell Bio Therapeutics Co
Moving against Vaxcell Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vaxcell Bio Therapeu Risk Profiles
Although Vaxcell Bio's alpha and beta are two of the key measurements used to evaluate Vaxcell Bio's performance over the market, the standard measures of volatility play an important role as well.
Vaxcell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vaxcell Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Other Information on Investing in Vaxcell Stock
Vaxcell Bio financial ratios help investors to determine whether Vaxcell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vaxcell with respect to the benefits of owning Vaxcell Bio security.